Details

Autor(en) / Beteiligte

• Rosales Morales, Karla Beatriz
• Pérez, Ramón Espinoza
• Cancino López, Jorge David
• Díaz, Evelin Reyes
• Chacón Pérez, Maya Jazmín
• Zavalza Camberos, Paloma Arleth
• Cheng, María del Carmen Ambrosio
• Cedillo Galindo, Héctor Arturo
• Morinelli Astorquizaga, María Alejandra
• Trejo Villeda, L.E. Miguel
• Sierra, Ramón Paniagua
• Hernández Rivera, Juan Carlos H.

Titel

Anemia and Erythrocytes: Behavior and Prevalence 1 Year After Kidney Transplant

Ist Teil von

• Transplantation proceedings, 2020-05, Vol.52 (4), p.1169-1172

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2020

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Renal transplantation presents multiple complications after its completion, some of them related to the behavior of hemoglobin levels. The objective of this study is to determine the behavior and prevalence of anemia and erythrocytosis in the first year after renal transplantation. A retrospective, observational study was conducted of a cohort of patients of the 21st Century National Medical Center in Mexico of transplants performed from January 1, 2013 to December 31, 2017. A total of 649 met the inclusion criteria. Pre-transplant hemoglobin (Hb) levels were determined, as well as levels 1 month, 3, 6, 9, and 12 months after transplantation, and the prevalence of anemia and erythrocytosis was determined in each month. Descriptive analysis was performed with measures of central tendency and measures of dispersion. The statistical program SPSS version 25 was used. The mean pre-transplant Hb was 10.69 g/dL (standard deviation [SD] 2.04). One year after the renal transplant, Hb averaged 14.45 g/dL (SD 2.30), which meant an increase over the first year after renal transplantation of 3.76 g/dL. Pre-transplant anemia occurred in 73.1% of patients, and erythrocytosis in 0.1%; 12.9% of patients and 5.9% in erythrocytosis continued with anemia for a year. Renal transplantation allows Hb levels to recover in a multifactorial way; however, the persistence of anemia and erythrocytes creates a study challenge in any transplant unit, due to their prevalence of 12.9 and 5.9% respectively